Volumetric changes and clinical trajectories in Parkinson’s disease: a prospective multicentric study

被引：0

作者：

Ana Marques

Elise Macias

Bruno Pereira

Elodie Durand

Carine Chassain

Tiphaine Vidal

Luc Defebvre

Nicolas Carriere

Valerie Fraix

Elena Moro

Stéphane Thobois

Elise Metereau

Graziella Mangone

Marie Vidailhet

Jean-Christophe Corvol

Stéphane Lehéricy

Nicolas Menjot de Champfleur

Christian Geny

Umberto Spampinato

Wassilios G. Meissner

Solène Frismand

Emmanuelle Schmitt

Anne Doé de Maindreville

Christophe Portefaix

Philippe Remy

Gilles Fénelon

Jean Luc Houeto

Olivier Colin

Olivier Rascol

Patrice Peran

Jean-Marie Bonny

Maria Livia Fantini

Franck Durif

机构：

[1] University Clermont Auvergne,Neurology Department and NS

[2] CNRS,PARK/FCRIN Network

[3] Clermont Auvergne INP,Department of Movement Disorder and NS

[4] IGCNC,PARK/FCRIN Network, Inserm 1172

[5] Institute Pascal,Département de Neurologie and NS

[6] Clermont-Ferrand University Hospital,PARK/FCRIN Network

[7] Clermont-Ferrand University Hospital,Department of Neuroradiology

[8] Biostatistics Unit (DRCI),Department of Geriatrics and NS

[9] University of Lille,PARK/FCRIN Network

[10] Université Grenoble Alpes,Service de Neurologie

[11] CHU de Grenoble,Maladies Neurodégénératives and NS

[12] Service de Neurologie,PARK/FCRIN Network

[13] Grenoble Institute of Neuroscience,Dept. Medicine

[14] and NS-PARK/FCRIN Network,Department of Neurology and NS

[15] CNRS,PARK/FCRIN Network

[16] Institut des Sciences Cognitives Marc Jeannerod,Department of Neuroradiology

[17] UMR 5229 CNRS,Department of Neurology and NS

[18] Université Claude Bernard,PARK/FCRIN Network

[19] Hospices Civils de Lyon,Department of Radiology

[20] Hôpital Neurologique Pierre Wertheimer,CReSTIC Laboratory

[21] Service de Neurologie C and NS-PARK/FCRIN Network,Centre Expert Parkinson, Départements de Pharmacologie Clinique et Neurosciences, Centre d’Investigation Clinique CIC 1436, UMR 1214 TONIC, NeuroToul and NS

[22] Sorbonne Université; Institut du Cerveau-ICM,PARK/FCRIN Network

[23] Assistance Publique Hôpitaux de Paris; Inserm 1127,Nuclear Magnetic Resonance Facility for Agronomy, Food and Health

[24] CNRS 7225,Département de Neuroradiologie and NS

[25] CIC Neurosciences,PARK/FCRIN Network

[26] Hôpital Pitié-Salpêtrière,Neurology Department

[27] Montpellier University Hospital Center,undefined

[28] Gui de Chauliac Hospital,undefined

[29] I2FH,undefined

[30] Institut d’Imagerie Fonctionnelle Humaine,undefined

[31] Hôpital Gui de Chauliac,undefined

[32] CHRU de Montpellier,undefined

[33] Montpellier University Hospital,undefined

[34] Montpellier University,undefined

[35] CHU Bordeaux,undefined

[36] INCIA-UMR 5287,undefined

[37] Team P3TN,undefined

[38] CNRS/Université de Bordeaux,undefined

[39] Univ. Bordeaux,undefined

[40] CNRS,undefined

[41] IMN,undefined

[42] UMR 5293,undefined

[43] University of Otago,undefined

[44] Nancy University Hospital Center,undefined

[45] Nancy University Hospital Center,undefined

[46] Hôpital Maison Blanche,undefined

[47] Hôpital Maison Blanche,undefined

[48] University of Reims Champagne-Ardenne,undefined

[49] Centre Expert Parkinson and NS-PARK/FCRIN Network,undefined

[50] CHU Henri Mondor; AP-HP et Equipe Neuropsychologie Interventionnelle,undefined

来源：

Journal of Neurology | 2023年 / 270卷

关键词：

Parkinson’s disease; Volumetric changes; Brain atrophy; Clinical progression; Longitudinal study;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：6033 / 6043

页数：10

共 404 条

[1] Greenland JC(2019)The clinical heterogeneity of Parkinson’s disease and its therapeutic implications Eur J Neurosci 49 328-338
[2] Williams-Gray CH(2006)Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism Lancet Neurol 5 355-363
[3] Barker RA(2018)Longitudinal Progression Markers of Parkinson’s Disease: Current View on Structural Imaging Curr Neurol Neurosci Rep 18 83-3179
[4] Schrag A(2013)A systematic review of biomarkers for disease progression in Parkinson’s disease BMC Neurol 13 35-2986
[5] Schott JM(2021)Progression of grey and white matter brain damage in Parkinson’s disease: a critical review of structural MRI literature J Neurol 268 3144-699
[6] Yang J(2020)Progressive brain atrophy and clinical evolution in Parkinson’s disease Neuroimage Clin 28 102374-184
[7] Burciu RG(2015)Baseline and longitudinal grey matter changes in newly diagnosed Parkinson’s disease: ICICLE-PD study Brain 138 2974-47
[8] Vaillancourt DE(2005)The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment J Am Geriatr Soc 53 695-442
[9] McGhee DJ(1992)Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatr 55 181-661
[10] Royle PL(2007)Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan Mov Disord 22 41-62

← 1 2 3 4 5 6 7 8 9 10 →